Inflammatory Marker Analysis in Psoriatic Skin Under topical Phospodiesterase 4 Inhibitor Treatment

Publication date: Available online 12 May 2017
Source:Journal of Allergy and Clinical Immunology
Author(s): Lennart M. Roesner, Petra Kienlin, Gabriele Begemann, Oliver Dittrich-Breiholz, Thomas Werfel

Teaser

Topical formulations of the two PDE4i roflumilast and TAK-084 lead to a reduction of inflammatory markers and infiltrating cells in psoriatic lesional skin.


http://ift.tt/2puH4yR